Skip to main content
. 2006 Aug 22;66(2):235–241. doi: 10.1136/ard.2006.057133

Table 5 European League Against Rheumatism Disease Activity Score response at 18 months33.

Combination SASP MTX
Good response, n (%) 7 (18) 3 (7) 2 (5)
Remission, n (%) 4 (10) 2 (5) 1 (3)
DAS
 Low 20 11 9
 Moderate 45 55 48
 High 14 20 31

DAS, disease activity score; MTX, methotrexate; SASP, sulfasalazine.